DecisionPoint Financial’s Eli Lilly LLY Stock Holding History

DecisionPoint Financial’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$300K	Buy	261 +233	+832%	+$275K	0.05%	52
2026 Q2	$33.6K	Hold	28	–	–	0.01%	122
2026 Q1	$25.9K	Hold	28	–	–	0.01%	119
2025 Q4	$30.2K	Hold	28	–	–	0.01%	113
2025 Q3	$23.2K	Hold	28	–	–	0.01%	108
2025 Q2	$21.8K	Buy	28 +7	+33%	+$5.44K	0.01%	120
2025 Q1	$17.4K	Buy	21 +5	+31%	+$4.16K	0.01%	132
2024 Q4	$12.4K	Hold	16	–	–	﹤0.01%	148
2024 Q3	$14.2K	Hold	16	–	–	﹤0.01%	137
2024 Q2	$12.9K	Buy	16 +2	+14%	+$1.6K	﹤0.01%	145
2024 Q1	$10.3K	Hold	14	–	–	﹤0.01%	160
2023 Q4	$8.16K	Sell	14 -3	-18%	-$1.75K	﹤0.01%	139
2023 Q3	$9.13K	Hold	17	–	–	﹤0.01%	128
2023 Q2	$7.97K	Hold	17	–	–	﹤0.01%	124
2023 Q1	$5.84K	Hold	17	–	–	﹤0.01%	126
2022 Q4	$6.22K	Buy	+17	New	+$6.03K	﹤0.01%	107

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Goelzer Investment Management Carmel, Indiana $2.28B AUM 31.27% 1-Year Est. Return

DecisionPoint Financial's LLY Position: Q3 2026 in Review

DecisionPoint Financial increased its Eli Lilly (LLY) stake by 832% in Q3 2026, buying an estimated $275K and bringing the position to 261 shares worth $300K. The position accounts for 0.05% of the portfolio, ranked #52.

DecisionPoint Financial first reported a position in LLY in Q4 2022 and has held it in 16 quarters since. 1,741 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

DecisionPoint Financial held 261 shares of Eli Lilly worth $300K as of Q3 2026.
DecisionPoint Financial bought 233 Eli Lilly shares in Q3 2026, an estimated $275K.
Eli Lilly made up 0.05% of DecisionPoint Financial's portfolio in Q3 2026, its #52 holding.
DecisionPoint Financial first reported a position in Eli Lilly in Q4 2022 and has held it in 16 quarters since.
1,741 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on DecisionPoint Financial's 13F filing for Q3 2026, filed 27 Oct 2026.